Fragmin injection/adult indications and dosage: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 13: Line 13:
* Deep venous thrombosis, In medical patients with severely restricted mobility due to acute illness; Prophylaxis
* Deep venous thrombosis, In medical patients with severely restricted mobility due to acute illness; Prophylaxis
* Postoperative deep vein thrombosis; Prophylaxis - Total replacement of hip
* Postoperative deep vein thrombosis; Prophylaxis - Total replacement of hip
{| style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="height: 30px; line-height: 30px; background: #104E8B; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Infection}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Drug A]] 50 mg/kg IV q8h'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Drug B]] 50 mg/kg IV q8—12h'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Drug C]] 50 mg/kg IV q8h'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Drug D]] 2.5 mg/kg IV q8h''''' <BR> OR <BR> ▸ '''''[[Drug E]] 2.5 mg/kg IV q8h'''''
|-
|}
|}





Revision as of 14:33, 19 March 2014

Fragmin injection®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Routes and Preparations
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Taking with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

FDA-Labeled Indications and Dosage (Adult)

  • Prophylaxis of Venous Thromboembolism Following Abdominal Surgery
Recommneded dose: 2500 IU SUBQ q24h (starting 1 to 2 hours prior to surgery) for 5 to 10 days.
High risk of thromboembolic complications: 5000 IU SUBQ q24h (starting the evening prior to surgery) for 5 to 10 days OR 2500 IU SUBQ 1 to 2 hours prior to surgery followed by 2500 IU 12 hours later and 5000 IU q24h thereafter for 5 to 10 days
  • Acute coronary syndrome, Associated with unstable angina or non-Q-wave myocardial infarction - Myocardial ischemia; Prophylaxis
  • Cancer - Venous thromboembolism
  • Deep venous thrombosis, In medical patients with severely restricted mobility due to acute illness; Prophylaxis
  • Postoperative deep vein thrombosis; Prophylaxis - Total replacement of hip


Off-Label Use and Dosage (Adult)

References